Breast Cancer Business, International Growth Drive up Genomic Health's Q2 Revenues 17 Percent

Net income in the second quarter rose 166 percent to $2.3 million, or $.08 per share, from $865,000, or $.03 a share, a year ago, edging out analysts' EPS expectations of $.02.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories